Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO(®) and OTEMTO(®) Studies

INTRODUCTION: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report recommends long-acting muscarinic antagonists (LAMA) or long-acting β(2)-agonists (LABA) as first-line treatment for chronic obstructive pulmonary disease (COPD), but many patients remain symptomatic on m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Adv Ther
Main Authors: Buhl, Roland, Singh, Dave, de la Hoz, Alberto, Xue, Wenqiong, Ferguson, Gary T.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370969/
https://ncbi.nlm.nih.gov/pubmed/32462607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01373-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares